Study of Controlled Release Formulations of CE-224,535 Against the Immediate Release Formulation in Normal Volunteers Study of Controlled Release Formulations of CE-224,535 Against the Immediate Release Formulation in ...
A Phase 1, Randomized, 4-Period, 4-Sequence Cross-Over Study Of The Pharmacokinetics Of 3 Durations Of Release Of A Controlled Release Formulation And A Single Dose Of An Immediate Release Oral Suspension Of CE-224,535 In Normal Healthy Volunteers A Phase 1, Randomized, 4-Period, 4-Sequence Cross-Over Study Of The Pharmacokinetics Of 3 Durations ...